Wed, November 3, 2021
Tue, November 2, 2021
Mon, November 1, 2021
Sun, October 31, 2021
Sat, October 30, 2021
Fri, October 29, 2021
Thu, October 28, 2021

Yatin Suneja Upgraded (ACAD) to Strong Buy and Held Target at $23 on, Nov 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-23-on-nov-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yatin Suneja of Guggenheim, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Strong Buy and Held Target at $23 on, Nov 1st, 2021.

Yatin has made no other calls on ACAD in the last 4 months.



There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 2 agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $20 on, Thursday, October 14th, 2021
  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $25 on, Thursday, August 5th, 2021


These are the ratings of the 2 analyists that currently disagree with Yatin


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $26 on, Thursday, August 5th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $28 on, Thursday, August 5th, 2021

Publication Contributing Sources